Kauppila Joonas H, Raatiniemi Lasse, Isokangas Juha-Matti, Martikainen Matti, Piironen Katja
Duodecim. 2017;133(2):167-71.
Thrombolysis with tissue plasminogen activator is the mainstay in the treatment of acute stroke. Reducing the delay of thrombolysis treatment improves patient prognosis and reduces the incidence of complications. Variable telestroke regimens have improved the availability of stroke thrombolysis, especially in rural settings, where neurologists are not readily available. In the drip-and-ship strategy, stroke thrombolysis is initiated in a peripheral hospital and the patient is then transferred to a tertiary care unit. We report the first case of drip-and-ship stroke thrombolysis in a rural health care center in Northeastern Finland.
使用组织型纤溶酶原激活剂进行溶栓是急性中风治疗的主要方法。减少溶栓治疗的延迟可改善患者预后并降低并发症发生率。各种远程卒中方案提高了中风溶栓的可及性，尤其是在农村地区，那里不容易找到神经科医生。在“边滴注边转运”策略中，中风溶栓在基层医院启动，然后患者被转至三级护理单位。我们报告了芬兰东北部一家农村医疗中心首例“边滴注边转运”中风溶栓病例。
